13F HOLDINGS REPORT
Saturn V Capital Management LLC
Quarter ended Q1 2023 · Filed February 9, 2023 · Accession 0001104659-23-014959
Total Value
$120.5M
Positions
19
Other Managers
0
Confidential Omitted
No
Holdings (19)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CRINETICS PHARMACEUTICALS IN | CRNX | 623,819 | $11.3M | 9.41% |
| 2 | 2SEVENTY BIO INC | 901384107 | 684,996 | $9.9M | 8.20% |
| 3 | APELLIS PHARMACEUTICALS INC | APLS | 212,329 | $9.4M | 7.81% |
| 4 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 487,179 | $8.8M | 7.29% |
| 5 | CYTOKINETICS INC | CYTK | 196,982 | $8.0M | 6.62% |
| 6 | ASCENDIS PHARMA A/S | ASND | 68,404 | $8.0M | 6.60% |
| 7 | MORPHIC HLDG INC | 61775R105 | 269,827 | $7.4M | 6.12% |
| 8 | ITEOS THERAPEUTICS INC | 46565G104 | 342,071 | $7.0M | 5.83% |
| 9 | ALBIREO PHARMA INC | 01345P106 | 341,827 | $6.9M | 5.70% |
| 10 | CHINOOK THERAPEUTICS INC | 16961L106 | 423,177 | $6.7M | 5.58% |
| 11 | KALVISTA PHARMACEUTICALS INC | KALV | 719,937 | $6.7M | 5.56% |
| 12 | CYMABAY THERAPEUTICS INC | 23257D103 | 1,611,778 | $5.7M | 4.75% |
| 13 | HORIZON THERAPEUTICS PLC | G46188101 | 69,170 | $5.7M | 4.71% |
| 14 | SAGE THERAPEUTICS INC | 78667J108 | 156,085 | $5.4M | 4.45% |
| 15 | AMICUS THERAPEUTICS INC | FOLD | 566,179 | $4.9M | 4.06% |
| 16 | BIOCRYST PHARMACEUTICALS INC | BCRX | 340,163 | $3.8M | 3.11% |
| 17 | BIOGEN INC | BIIB | 7,660 | $2.2M | 1.80% |
| 18 | ASTRIA THERAPEUTICS INC | 04635X102 | 169,493 | $1.6M | 1.29% |
| 19 | THERAVANCE BIOPHARMA INC | TBPH | 141,339 | $1.3M | 1.11% |